Codexis/ US1920051067 /
6/24/2022 9:59:58 PM | Chg. +1.42 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
11.44USD | +14.17% | 81,626 Turnover: 890,998.28 |
-Bid Size: - | -Ask Size: - | 11.44 | 10.43 |
GlobeNewswire
2/10
Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24
GlobeNewswire
1/24
Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treat...
GlobeNewswire
12/15/2021
Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays fo...
GlobeNewswire
11/22/2021
Codexis Presents Pre-Clinical Data Highlighting its Programs in Homocystinuria and Maple Syrup Urine...
GlobeNewswire
11/15/2021
Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development
GlobeNewswire
11/15/2021
Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th Internationa...
GlobeNewswire
11/4/2021
The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 m...
GlobeNewswire
11/3/2021
Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancrea...
GlobeNewswire
10/18/2021
Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost ...
GlobeNewswire
9/9/2021
Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin
GlobeNewswire
8/25/2021
Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global ...
GlobeNewswire
8/2/2021
Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce...